Pluri Stock (NASDAQ: PLUR) stock price, news, charts, stock research, profile.
Open | $5.48 |
Close | $5.45 |
Volume / Avg. | 4.24K / 7.92K |
Day Range | 5.38 - 5.99 |
52 Wk Range | 3.45 - 8.48 |
Market Cap | $30.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 0.49% |
Days to Cover | 2.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pluri (NASDAQ:PLUR) through any online brokerage.
Other companies in Pluri’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).
There is no analysis for Pluri.
There is no analysis for Pluri to provide a consensus price target.
The stock price for Pluri (NASDAQ: PLUR) is $5.75 last updated July 18, 2024 at 9:09 AM EDT.
There are no upcoming dividends for Pluri.
Pluri’s Q4 earnings are confirmed for Tuesday, September 10, 2024.
There is no upcoming split for Pluri.
Pluri is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.